Concerns About Albendazole Treatment for Hookworm
Author Information
Author(s): Montresor Antonio, Engels Dirk, Chitsulo Lester, Gabrielli Albis, Albonico Marco, Savioli Lorenzo, Lammie Patrick
Primary Institution: World Health Organization
Hypothesis
The cure rate is not a valid indicator for assessing drug efficacy in treating hookworm infections.
Conclusion
The authors argue that the egg reduction rate is a more appropriate measure of drug efficacy than the cure rate.
Supporting Evidence
- The authors argue that cure rates are influenced by infection intensity and testing methods.
- The egg reduction rate shows over 80% efficacy for albendazole against hookworms.
- The main goal of treatment is to reduce the number of worms, not just to cure individuals.
- The WHO continues to recommend mebendazole and pyrantel for treating STH infections.
Takeaway
The study says that just counting how many people are cured isn't enough to know if a medicine works well against hookworms; we should look at how many eggs are reduced instead.
Potential Biases
The authors express concern about potential bias in interpreting drug efficacy based on cure rates.
Limitations
The commentary does not provide original data but critiques another study's methodology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website